Primemd Inc. (PRMD)

Primemd Cash Flow Statement

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2008	FY 2007	FY 2006	FY 2005	FY 2004
Period Ending	Dec 31, 2008	Mar 31, 2008	Mar 31, 2007	Mar 31, 2006	Mar 31, 2005	Mar 31, 2004
Net Income	-0.08	-0.1	0.19	-0.16	-0.16	-0.15
Depreciation & Amortization	0	0	0	0.01	0.01	0.02
Loss (Gain) From Sale of Assets	-	-	0.02	-	-0	-0
Loss (Gain) From Sale of Investments	-	-0.04	-	-	-0	-
Loss (Gain) on Equity Investments	0.05	0.05	-0.37	0.02	-	-
Change in Accounts Receivable	0.01	-0	0	-0	-0	0.01
Change in Accounts Payable	0.01	-0	0	-0	-0	0
Change in Other Net Operating Assets	-0	-0	-0.01	-	-	-
Operating Cash Flow	-0.01	-0.09	-0.16	-0.14	-0.16	-0.12
Capital Expenditures	-	-	-	-	-0	-0.03
Sale of Property, Plant & Equipment	-	-	-	-	-	0.01
Sale (Purchase) of Real Estate	-	-	-	-	0.3	0
Investment in Securities	-	-0.04	-0.04	-0.05	0.53	-0.3
Other Investing Activities	-	-	-	-	-	-0.01
Investing Cash Flow	-	-0.04	-0.04	-0.05	0.83	-0.33
Net Cash Flow	-0.01	-0.13	-0.2	-0.19	0.67	-0.46
Free Cash Flow	-0.01	-0.09	-0.16	-0.14	-0.16	-0.16
Free Cash Flow Margin	-19.50%	-133.95%	-330.19%	-258.13%	-411.74%	-268.14%
Free Cash Flow Per Share	-0.00	-0.03	-0.05	-0.04	-0.05	-0.05
Levered Free Cash Flow	0.35	0.05	-0.14	-0.1	-0.12	-0.11
Unlevered Free Cash Flow	0.35	0.05	-0.14	-0.1	-0.12	-0.11
Change in Working Capital	0.01	-0.01	-0.01	-0.01	-0	0.01

Source: S&P Global Market Intelligence. Standard template. Financial Sources.